Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

Get Ready for World TB Day March 24, 2013!

WTBD 2013

World TB Day is celebrated on March 24 and there is a lot going on during this week and next to highlight the continued problem of TB in the world and the solutions to address the problem. Included is a list of publications, news items, events, and links related to TB and World TB Day 2013.

27 Nov 2012
by Working Group

Posted in Events, TB Drug Development, TB News, TB Treatment

Recap from the 43rd Union World Conference in Kuala Lumpur

Visuel 8,5 x 11 inch.indd

The week of November 12th was exciting with the 43rd Union World Conference, the WGND Annual Meeting (will be posting presentations soon), and the Stop TB Coordinating Board Meeting. Included are some news highlights and a listing of webcasts of interesting and presentations relevant for TB drug development and research.

The Growing Landscape of TB Trials: Interview with Dr. Andrew Vernon

thumb206-andy

This week we highlight an interview with Dr. Andrew Vernon, the Chief, Clinical Research Branch, Division of Tuberculosis Elimination at the U.S. Centers for Disease Control and Prevention (CDC). He discusses the progress made in TB drug development and the growing number of TB trials and trials groups.

15 Aug 2012

2012 WGND Annual Meeting is Nov 14 in Kuala Lumpur

2010 Annual Meeting

We will have our 2012 Annual Meeting in Kuala, Lumpur on Wednesday, November 14 at the Impiana KLCC Hotel from 13:00 to 17:30. The meeting will be held in conjunction with the 43rd Union World Conference on Lung Health.

13 Sep 2011
by Working Group

Posted in Action, Announcements, Events

REGISTRATION OPEN! WGND Annual Meeting and Dinner 2011

info sign

We invite you to join us for the Stop TB Partnership Working Group on New Drugs’ Annual Meeting 2011 at the Grand Palais in Lille, France, on October 26. Also, we are sponsoring a dinner on October 25 at Le Barbue d’Anvers in Lille to allow our Sub-groups (Biology/Targets, Candidates, Critical Knowledge and Tools, and Clinical Trial Capacity) to meet and plan for activities for 2012. Please make plans to attend both events.

1 Sep 2011

New TB Materials and Tools Available!

info sign

Over the last week, some announcements have been released concerning new tools, publications and meeting materials that may be of value to the TB community including materials from the WGND sponsored “Essentiality of Pyrazinamide” Workshop, an interactive map of clinical trials from PACTR, and a new Collaborative Framework for Care and Control of Tuberculosis and Diabetes from the WHO and The Union.

TB R&D Weekly Update: Podcast Interview with Armand Van Deun

This week’s interview is with Dr. Armand Van Deun who was the recipient of the 2010 Stop TB Partnership-Kochon Foundation prize. Last year, Dr. Van Deun, et al., published an article in the American Journal of Respiratory and Critical Care Medicine entitled “Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis”. In the interview, we discuss this article which presents the results of an observational study in Bangladesh of a treatment for multidrug-resistant TB that incorporates fourth-generation fluoroquinolone combined with other second-line drugs and supplemented by potentially still active first-line drugs. Additional links to TB R&D News are included.

TB R&D Weekly Update: Promoting Fixed-dose Combos for TB control

the union

In this week’s article, Monedero and Caminero conduct a critical review of research on the use of fixed-dosed combinations (FDCs) for tuberculosis with the conclusion that FDCs should continue to be promoted and recommended. Additional links to TB R&D News are included.

New Report on Drugs for Drug-resistant TB

cover msf union report

The Médecins Sans Frontières and The Union will release on World TB Day a new report entitled “DR-TB drugs under the microscope” outlining drugs currently available to treat drug-resistant tuberculosis (DR-TB) including product information, sources of the drug, quality status, and price.

15 Nov 2010

Berlin 2010: Gerry Elsdon interview

“Bring Tuberculosis Out Of The Dark Into Light…” so said Gerry Elsdon, the very svelte TV broadcaster from South Africa, during the 10th anniversary celebrations of the Global Alliance for TB Drug Development (TB Alliance), during the 41st Union World Conference on Lung Health, Berlin, Germany (11-15 November 2010).